Metacognition as a mediating variable between neurocognition and functional outcome in first-episode psychosis by Davies, Geoff et al.
1 
METACOGNITION IN FIRST-EPISODE PSYCHOSIS 
Metacognition as a mediating variable between 
neurocognition and functional outcome in first-
episode psychosis. 
 
Geoff Davies1 (Corresponding author) 
David Fowler1 
Kathryn Greenwood1 
 
1Department of Psychology, University of Sussex, Brighton, UK 
 
Abstract word count: 228 
Main text word count: 4221 
Correspondence address: 
School of Psychology 
University of Sussex 
Falmer, 
Brighton 
BN1 9QH 
Geoff.davies@sussex.ac.uk 
  
2 
METACOGNITION IN FIRST-EPISODE PSYCHOSIS 
Abstract 
Background: Neurocognitive and functional outcome deficits have long been acknowledged in 
schizophrenia and neurocognition has been found to account for functional disability to a 
greater extent than psychopathology. Much of the variance in functional outcome however 
still remains unexplained and metacognition may mediate the relationship between 
neurocognition, functional capacity, and self-reported social and occupational function. 
Method: 80 first-episode psychosis participants were recruited and completed measures of 
neurocognition (memory, executive function and IQ), metacognition (Beck Cognitive Insight 
Scale, Metacognitive Awareness Interview), psychopathology (PANSS), and both functional 
capacity (UPSA) and real-life social and occupational function (The Time Use Survey). Path 
analyses investigated the relationships between variables through Structural Equation 
Modelling. Results: A series of path models demonstrated that metacognition partially 
mediates the relationship between neurocognition and functional capacity, and fully 
mediates the relationship between functional capacity and social and occupational function. 
Conclusion: The present study findings identify that metacognition may be critical to 
translating cognitive and functional skills into real-world contexts, and this relationship is 
found at early stages of illness. Understanding how individuals translate cognitive and 
functional skills into the real-world (the competence-performance gap) may offer valuable 
guidance to intervention programmes. This finding is important to models of recovery as it 
suggests that intervention programmes that focus on enhancing metacognition abilities may 
have a greater impact than traditional rehabilitation programmes focusing on cognitive 
abilities, on social and occupational outcomes.  
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Introduction 
Neurocognitive deficits in schizophrenia are considered a core feature of the disorder1 and a 
vulnerability marker for later illness development2. Cognitive ability may also predict functional 
recovery in the community3,4. Better cognitive performance has been associated with improved 
self-reported quality of life5, social and occupational outcomes6,7 and these associations persist in 
longitudinal designs (see Green, Kern, & Heaton, 2004 or Lepage, Bodnar & Bowie, 2014 for a 
review). Cognitive and functional disability are also credible treatment targets10. This association 
of improved cognitive skills with improved functional outcome led to the introduction of 
cognitive remediation programmes aiming to improve an individual’s cognitive skills, and 
thereby functional recovery and real world community outcomes11. However, currently the 
evidence for the impact on to real-world improvements in functional status is equivocal12. Some 
reviews suggest that neurocognition only accounts for around 40% of the relationship between 
cognitive ability and functional outcome, which suggests that 60% of the relationship remains 
unexplained13. The link between neurocognition and functional outcome is perhaps not direct 
and this has led some to the search for mediating variables to account for the relationship13. 
 
Metacognition has been proposed as a candidate variable to explain the unaccounted variance in 
the relationship between neurocognition14 and functional outcome15 in schizophrenia. 
Metacognition is broadly defined as ‘thinking about thinking16 and relates to our ability to inspect 
cognitive products and mental states17 and objectively scrutinise them18. This higher-order ability 
draws upon cognitive skills to process self-referential information and may be essential to the 
integration of raw cognitive processing into a complex and constantly evolving social world19. 
Thus it is what we know that we know, that is important20. Being unaware of erroneous decisions 
(possibly as a result of underlying neurocognitive deficits) may lead to inaccurate social 
interpretations and poor behavioural response choices fostering functional disability.  
 
Metacognition can be both conceptualised and measured in a number of ways. One particular 
conceptualisation (synthetic metacognition) has been to assess an individual’s ability to describe 
and reflect back on their own cognition, differentiate between mental state transitions, their 
relationship to emotion and behaviour and to differentiate between one’s own and the mental 
states of others21,22. Other authors have conceptualised metacognition as the insight we have into 
the fallibility of our own cognition (cognitive insight)23 or the appropriate level of confidence 
applied to cognition-based decisions (metacognitive accuracy)24. Relationships have been found 
between metacognition and functioning25,26 and neurocognition27 although the findings for 
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metacognition as cognitive insight appear more mixed28. Metacognition has been found to 
mediate the relationship between neurocognition and social functioning in a chronic 
schizophrenia sample26. However, it is not known if this finding would be replicated in first 
episode psychosis or if metacognition predicts real world function26. Most research in this area 
has been completed on chronic cohorts which introduces confounds. In studies the use of 
chronic cohorts makes findings difficult to interpret as the effects on neurocognition and 
metacognition are difficult to disentangle from the longer-term impact of neuroleptic medication 
and differing access to long term contact with psychiatric services and psychological therapies29. 
Past researchers have also tended to employ only one measure of outcome (the frequency of 
social contacts) whereas functional recovery encompasses a variety of domains including 
occupational30, social31 and capacity skills32.  
In relation to functional outcome, metacognition may offer a unique account for functional 
disability aside from the known relationship with cognition. Metacognition has been found to 
associate with both social cognition and cognition26 and factor analytic investigations have found 
it to load on a separate construct to both33. Metacognition uses similar skills to mentalization but 
specifically addresses the application of these mentalization skills into social contexts. 
Assessment of functional outcome has become increasingly sophisticated in recent years with 
authors beginning to acknowledge the distinction between what one can do (functional capacity) 
from what one actually does in real-life. Assessments of functional capacity attempt to provide 
objective measures of current functional ability free from the impact of social factors such as 
denial of opportunity34. Functional capacity has been found to mediate the relationship between 
neurocognition and real-world function35. Gupta and colleagues36 found that a larger 
competence-performance gap is associated with earlier onset of illness, depressive symptoms and 
greater time in hospital suggesting a complex relationship between the variables. 
In summary metacognition, having the ability to reflect back and learn, may be critical to the 
initiation, integrating and application of cognitive skills into real-world situations. These 
metacognitive skills may aid the learning of new information, improve social and occupational 
recovery and promote self-management in the community. Incorporating metacognitive 
processing into cognitive remediation programmes has already begun in trials with positive 
results thus far37. However, research is needed to clarify how metacognition impacts on the 
relationship between neurocognition and both functional capacity and social and occupational 
function. To date few designs have differentiated between these variables.  
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The present study investigated the association between metacognition, neurocognition, and both 
functional capacity and social and occupational functioning in a cohort of people with first 
episode psychosis using structural equation modelling. We predicted that metacognition would 
mediate the relationship between neurocognition and functional capacity (assessed by 
performance skills assessment UPSA) and secondly that metacognition will mediate the 
relationship between functional capacity and real-world functioning (assessed by time use). This 
is the first study of its type with first episode psychosis. 
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Method 
Participants 
Participants were recruited From Early Intervention in Psychosis (EIP) services in Sussex, UK. 
Ethical approval was obtained (Ref: 11/LO/1877, project ID 72141). All participants gave 
informed written consent to enter the research study. The study inclusion criteria were: A current 
diagnosis of FEP and being over the age of 18. Exclusion criteria were: A primary diagnosis of 
substance misuse or organic neurological impairment or insufficient English language skills to 
complete the assessments. Demographic and medication information was recorded and 
medication converted to Olanzapine atypical equivalents using conversion tables from Leucht 
and colleagues38. 
Measures 
Neurocognition 
Several specific domains of neurocognitive function known to be impaired in schizophrenia and 
psychosis were selected as previous research identifies the need for more comprehensive and 
more standardised39 measurement of neurocognitive impairment.  
 
Verbal and working memory were assessed using the Logical Memory and Letter-Number 
Sequencing subscales from the Wechsler Memory Scale (WMS-III)40. Executive function was 
assessed through phonological and semantic41 Verbal Fluency, and the Trailmaking Task. IQ was 
captured through the Wechsler Abbreviated Scale of Intelligence42.  
Metacognition  
Metacognition was assessed through two measures; the Metacognitive Assessment Interview 
(MAI)43 and the Beck Cognitive Insight Scale (BCIS)23. These measures were selected for their 
frequency of use as metacognitive measures in psychosis and schizophrenia and shared loading 
in a factor analysis investigation33. The MAI is an adaptation of the Metacognitive Assessment 
Scale (MAS)22 and based on the same theoretical framework42 but is less time consuming to 
administer as metacognitive function is directly questioned as opposed to assessing a 
standardised psychiatric interview retrospectively. The MAS upon which the MAI is based has 
been validated across numerous clinical populations17 including FEP44 and schizophrenia19 and 
the MAI has been validated in a clinical population45. 
The MAI is a semi-structured clinical interview designed to assess 4 domains of metacognition; 
monitoring, integration, differentiation and decentralisation. A manualised set of interview questions are 
conducted, with the participant response guiding the interview sequence to assess the 
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aforementioned domains. The monitoring subsection is comprised of questions that capture the 
interviewee’s ability to identify and monitor the thoughts and emotions that make up their own 
mental state. The integration subscale assesses the individual’s ability to reflect back on the 
transitions between their own mental states and identify causal reasons behind the transitions. 
The differentiation subscale assesses the individual’s ability to consider their point of view as 
subjective and fallible and distinguish between fantasies, beliefs and assumptions about reality in 
relation to factual events. The final decentralisation subscale requires the participant to describe and 
interpret the mental state of another person and to understand how that person’s beliefs, values 
and perspectives are separate from their own.  
The BCIS captures the participant’s self-reported ability to reflect on their own cognitive 
products, distance themselves from and re-evaluate thoughts, beliefs, and subjective 
interpretations23. It comprises 2 subscales; the self-reflectiveness scale assesses the individual’s 
willingness to reflect upon and be objective about thoughts. The self-certainty subscale relates to 
the individual’s certainty about being right and their resistance to correction. This information is 
measured through 15 self-report questionnaire items rated from 0 (do not agree at all) to 3 (agree 
completely). The BCIS has been assessed for validity and reliability23 46 and employed in FEP48. 
 
Symptoms 
Symptoms were measured by the Positive and Negative Syndrome Scale (PANSS)49. The PANSS 
has been well validated in research50 and employed in FEP44. 
 
Functioning 
Function was measured through two methods; functional capacity and self-reported social and 
occupational functioning (SOF). Functional capacity was measured by the UCSD Performance-
Based Skills Assessment (UPSA)51 and SOF was captured by the Time Use Survey52. The UPSA 
is an instrument to assess capacity to complete everyday tasks across five domains; finance, 
communication, comprehension and planning, transportation and household chores. The UPSA 
has been assessed for reliability and validated in schizophrenia52 and employed in FEP before53 54. 
 
The Time Use Survey51 is a semi-structured interview in which the participant is asked about the 
amount of time spent undertaking a variety of activities in the preceding month. The activities 
capture a host of functional domains including employment, education, voluntary work, leisure 
and sport, childcare and household maintenance. The total time spent in structured activities was 
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calculated from the aforementioned domains and included in analysis as a measure of SOF. The 
Time Use survey has been used in healthy individuals, FEP and CHR groups56 in previous 
research. 
 
Data Analysis 
First, descriptive statistics for all variables were computed using SPSS version 22 and inspected 
for normality and suitability for factor analysis. Second, preliminary relationships between 
variables were investigated through correlation analysis. The factor structure of observed 
variables was next explored using Mplus version 6. Factor structure was assessed through 
Confirmatory Factor Analysis (CFA) where pre-existing data was available and Exploratory 
Structural Equation Modeling (ESEM) where no existing research had assessed factor structure 
in the population. 
 
Third, Mediation analyses were conducted using Mplus (version 6), to investigate the 
relationships between the key factors of neurocognition, functional capacity and SOF, with 
metacognition as a mediator. The role of negative symptoms was also explored. The mediation 
model was investigated through indirect pathway statistics and Confidence Intervals (CI) derived 
through bootstrapping as suggested by Preacher and Hayes56. To support the direction of the 
relationships investigated, reverse models were also assessed. Lastly, to rule out the role of 
medication, the relationship between Olanzapine equivalent and metacognitive variables and 
function was investigated through correlation analysis. 
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Results 
Sample statistics 
Eighty FEP patients were recruited in total, mean age 26.08 (SD. 5.53, range 18-40) and the 
sample was comprised of 49 male and 31 female patients (see table 1 for demographic 
information).  
[Insert table 1 here] 
The means and standard deviations of the neurocognitive, metacognitive and functional capacity 
and outcome variables are available in table 2 below. Detailed test statistics are provided in table 
3 and 4. In addition appropriate summary test statistics (r values) have been included throughout. 
Missing data was treated as Missing at Random (MAR) therefore a maximum likelihood model 
estimation was used to address missing data issues as the default in Mplus. 
 
Model selection and assessment was made using the criteria outlined by Preacher and Hayes57 
where bootstrapping and confidence intervals are advised to assess the presence of mediation 
rather than the more traditional Baron and Kenny approach. 
[Insert table 2 here] 
Factor analysis 
A CFA confirmed that neurocognition was a 1-factor solution containing verbal and working 
memory, executive function, verbal and performance IQ. The model demonstrated an acceptable 
fit to the observed data (𝜒2 (29) = 29.55, p=.06, CFI= 0.96, TLI=0.95 RMSEA= 0.08). An 
ESEM analysis suggested that metacognition was best captured by the BCIS self-reflectivity and 
MAI total score. The CFA for functional capacity suggested that a 1-factor solution offered 
acceptable model fit statistics test (𝜒2 (5)=10.59, p=.06, CFI= .94, TLI= .89, RMSEA= .13). Self-
reported social and occupational function was included a single item observed variable in 
mediation analysis. 
 
Correlation analysis 
 [Insert table 3 here] 
 
Table 3 reveals that, as suggested by previous research, neurocognitive ability is significantly 
associated with one’s ability to conduct everyday tasks (functional capacity) and the amount of 
time spent in structured activities (SOF). Higher neurocognitive ability is associated with better 
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individual functioning. The analysis also demonstrates that metacognitive ability, both measured 
by the MAI and the BCIS self-reflectivity scale, is positively associated with both functional 
capacity and SOF. This suggests that better metacognitive function is associated with greater 
capacity to complete daily living tasks and spending more time in structured activities. Due to the 
high correlation between neurocognition and education level, neurocognition alone was selected 
for further analysis. No significant relationship was found between medication dose and 
metacognition (p=.687) or functional capacity (p=.407) or SOF (p=.369) so excluded from 
further analysis. 
Path Analysis 
To replicate existing work, the role of functional capacity in mediating the relationship between 
neurocognition and SOF was investigated and a significant mediation pathway was found. In 
order to test the mediating effect of metacognition on the relationship between neurocognition 
and functional capacity, model 1 (figure 1 below) was tested. A significant direct pathway was 
found between neurocognition and both functional capacity (p<.001) and metacognition (p=.02) 
and between metacognition and functional capacity (p=.005). The mediation model was then run 
and metacognition significantly mediated the relationship between neurocognition and functional 
capacity (𝛽=.29, p=.009, +/-95%[ .07, .50]). As the direct pathway remained significant in the 
mediation model the data is consistent with partial mediation. The mediation model accounted 
for 67% (R2 =.67) of the variation in capacity to complete simulated daily living tasks and 31% of 
the variation in metacognitive ability (R2 =.31). The reverse model (X and Y reversed and Y and 
M reversed) was not significant. Additional models were run with a significant secondary 
mediation pathway through negative symptoms and negative symptoms as an individual 
mediator of cognition and functional capacity. However introducing negative symptoms into the 
model led to the model fit statistics (CFI, TFI and chi square model fit) deteriorated below what 
is considered acceptable model fit therefore the simple model with only metacognition was 
selected. 
 
[insert fig 1 here] 
 
Next, the relationship between functional capacity and SOF was assessed, with metacognition as 
a mediator (figure 2 below). Metacognition significantly mediated the relationship between 
functional capacity and SOF as evidenced by the indirect path (𝛽=.41, p=.001, 95%CI [.31, .64]). 
Interestingly, as the direct path is not significant, this suggests the presence of full mediation and 
the model accounted for 66% of the variance in SOF (R2= .66). The reverse model was not 
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significant. Alternative models were also run and metacognition was found to significantly 
mediate the relationship between neurocognition and SOF (available in table 4. Table 4 contains 
the indirect (mediation) path statistics, CIs and overall model fit statistics). This confirms that the 
ability to conduct daily tasks and the ability to scrutinise cognitive products are implicated in 
translating cognitive abilities into real-life contexts. 
[insert fig 2 about here] 
[Insert table 4 here]  
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Discussion 
 
The present study offers two important findings; a) that metacognition partially mediates the 
relationship between neurocognition and functional capacity, and b) that metacognition fully 
mediates the relationship between functional capacity and SOF. All models reported 
demonstrated acceptable model fit statistics (table 4) and the effect sizes (R2) are large adding to 
the importance of the present work. In relation to the hypotheses, hypothesis one that 
metacognition would significantly mediate the relationship between neurocognition and 
functional capacity, was partially accepted as a significant partial mediation relationship was 
found. Hypothesis two that metacognition would significantly mediate the relationship between 
functional capacity and SOF was fully supported.  
 
Neurocognition and functional capacity 
The mediation analysis found that metacognition partially mediates the relationship between 
neurocognition and functional capacity explaining 67% of the overall variance in functional 
capacity. This suggests that raw cognitive ability may not be sufficient in itself to successfully 
complete everyday tasks but rather the metacognitive ability to accurately reflect back on 
cognition may be a key ingredient in equipping those recovering from psychosis to apply these 
cognitive process to function effectively.  
 
Functional capacity and SOF 
In terms of the relationship between functional capacity and SOF, metacognition was found to 
fully mediate this relationship. This is an important finding as this suggests that, whilst 
individuals may possess the capacity to complete tasks essential to community function, without 
sufficient metacognitive abilities, these skills may not be initiated, integrated and applied 
successfully to support real-world function and recovery. This finding suggest that metacognition 
and the ability to reflect back on cognitive products and accurately identify their relationship to 
emotions and behaviour in both the self and others, is critical to translating cognitive skills into 
real-world behaviour. 
 
In terms of the relationship between neurocognition and metacognition, the present study 
corroborates the work of Hamm et al.,58 Nicolò et al.,14 and Abu-Akel and Bo59 and a host of 
papers by Paul Lysaker17,21,26 in which improved neurocognition is associated with better 
metacognition. The present sample report similar scores to a paper by Lepage28 in FEP on both 
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self-reflectivity (mean 13 versus the present study 15.88) and self-certainty subscales (7.9 versus 
the present study 5.88). The work available on synthetic metacognition is more difficult to 
compare as the other studies in the area45 29 used a slightly different measure. The present study 
does however offer corollary support in that deficits in metacognition are present in FEP 
however goes further by offering an account for the relationship between neurocognition and 
functional outcome. The findings that self-reflectivity but not self-certainty loaded onto an 
overall metacognitive factor is interesting and can be accounted for by known work in the area. 
Gilleen, David and Greenwood60 found a relationship between self-reflectivity and awareness but 
not with self-certainty. Self-certainty may be more related to pathology and delusional thinking 
than higher-order synthetic metacognition. The present study also confirms that metacognition is 
an important determinant of community function as suggested by Giusti et al.,25 and Brüne et 
al.,18 . These studies were predominantly obtained in chronic samples however and this is the 
first study in first episode psychosis. 
 
The present study builds on Lysaker et al.'s26 study which found that metacognition mediated the 
relationship between cognition and social function. The present study extends this finding going 
on to demonstrate that this mediation effect may also be found using a measure of real life 
function (time use), as well as functional capacity (UPSA) and using a richer overall construct of 
metacognition. The present study was conducted in first episode psychosis which minimises the 
problems of interpretation associated with findings from chronic participants due to 
confounding with chronicity of illness and associated medication and treatment therapy 
exposure. The present paper adds to our understanding of the competence-performance gap35 by 
suggesting that metacognition may account for the disparity in the ability to complete daily living 
tasks, and actually performing them in the community. The present findings may imply that that 
the relationship between cognition and functional outcome may be a multi-step pathway, with 
metacognition as well as social cognitive and belief driven causal mechanisms. While Green, 
Llerena and Kern61 have discussed this possibility, they suggest that a single pathway through 
social cognition is the most parsimonious solution.  
The role of social cognition was not investigated in the present study although has been 
investigated at length elsewhere8 30. However some shared relationship between the MAI domain 
understanding the mind of others and social cognitive domains such as theory of mind would be 
expected as both require the individual to adopt the perspective of others which may be key to a 
host of functional domains such as social relationships and occupational functioning. A future 
study investigating the relationship between social cognitive and metacognitive variables on 
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different aspects of functional outcome would be valuable to understand the unique contribution 
each offers different aspects of community functioning. Our findings suggest that metacognition 
may be a key mediating variable which is able to offer an account for how these pathways 
interact. 
 
This study had methodological strengths in contrast to previous studies using chronic samples. 
No significant relationships were found between medication and metacognitive domains or 
outcome domains in this first episode sample thus the impact of medication may be minimised. 
Furthermore although the sample was still predominantly male, the ratio was much more even 
(61% male versus 39% female) than in past studies. This is also the first study to incorporate 
cognitive insight into this analysis and suggests that self-reflectivity may contribute to community 
function in addition to cognitive ability. 
 
In addition to work with CRT, the present study adds to the evidence base supporting treatment 
initiatives such as the Metacognitive Reflection and Insight Therapy (MERIT) and 
Neurocognitive Enhancement Therapy (NET) which also directly target the mechanisms 
discussed in the present paper for development in psychotherapy. MERIT seeks to assist those 
in treatment with developing a more complex narrative of their own mental lives and to be able 
to reflect on interpersonal events to better assist reducing social disability62. The present study 
offers a clear link between these abilities and their importance to improving functional outcome 
at early stage of illness. One of the key outcomes for NET has been identified as translating 
cognitive skills into real-world benefits63 and the present study demonstrates that metacognitive 
ability may be key to facilitating this. 
 
Engaging in normative social and occupational activity64 and participating in social and 
meaningful activity65 have been identified as key to personal recovery66. Thus a greater 
understanding of factors that allow individuals to maintain or regain these structured activities is 
crucial to treatments to improve functional outcome 
 
The study findings are of clinical relevance as they suggests that cognitive abilities are an 
important determinant of the capacity to complete everyday tasks however metacognition is also 
required to navigate the complexities of daily life. When it comes to translating these skills into a 
real-world setting, targeting metacognition is potentially at least as important as a focus on raw 
cognitive ability which may be less amenable to intervention. In summary, one’s ability to reflect 
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back on cognition and monitor the transitions between mental states may improve both the 
capacity to complete daily tasks and apply these competencies to real-world situations. 
 
Limitations 
Whilst the present study attempted to address many of the identified issues with known research, 
a number of limitations must be held in mind when considering the findings. Firstly, the present 
study is cross-sectional so the impact of changes in neurocognition and metacognition and how 
these may impact on functional levels in the individual are not known. The reverse model testing 
offers support to the direction of effects however Maxwell and Cole67 warn against claims of 
causation when employing cross-sectional data. Future studies tracking the changes in all three 
domains across time would offer greater insight into the mechanisms of the temporal 
relationship between variables.  
 
The MAI, as a measure of synthetic metacognitive ability, relies on self-report of internal 
mechanisms. Language disturbances have been identified as a primary feature of schizophrenia68 
or as a result of current symptoms69. As a self-report interview measure reliant upon 
verbalisation of internal experiences, deficits may be due to linguistic deficits or descriptive 
impairment rather than metacognition per se. However as one of the measures of 
neurocognition is verbal IQ, logical memory and verbal fluency also draw on these abilities, both 
neurocognition and metacognition measurement would have been impacted on by language 
deficits in the study.  
 
Secondly, the present study was potentially underpowered however sample size was acceptable 
for simple path analysis to detect mediation effects according to Fritz and MacKinnon70. In 
addition to maximise power, the models assessed were restricted; ideally the path models would 
have been measurement models with all indicators included however the present study had to 
approach this in a stepwise manner and run through multiple models to maintain a respectable 
case to parameter ratio71. Finally, due to the poor factor loading of self-certainty, the latent 
variable of metacognition was only measured by two indicators. Whilst Kenny suggests this as a 
minimum number, three is a safer option72 and under estimation may lead to biased parameter 
estimates73. The significant correlation however between the two indicators helps to justify the 
use of only two indicators. 
 
Implications 
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Despite these restrictions, the present study implicates metacognition in both functional capacity 
and real-world functioning. This confirms the relationship between neurocognition and function 
being mediated by metacognition. This also demonstrates that this relationship is present at early 
stages of illness. Metacognition may be a critical ingredient in initiating, integrating and applying 
a host of skills into occupational and social situations and this may suggest that treatment 
programmes may wish to target this ability in care pathways. Cognitive remediation programmes 
have already started to incorporate metacognitive content to traditional cognitive remediation 
exercises36 and the present study suggests that this is a valuable addition. By improving both 
cognition and metacognition rather than solely the former, recovery from psychosis after 
symptoms have subsided may be maximised. The effect sizes (variance accounted for) were also 
larger than previous studies investigating the relationship between neurocognition and function 
accounting for a large proportion of the overall variance in outcome. This offers far more 
explanation of functioning and highlights the importance of metacognition in functional 
outcome. 
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List of figures 
Figure 1: Mediation of the effect of neurocognition on functional capacity through metacognition. 
***p<.001, ** p<.01, *p<.05 
 
Figure 2: Suggested mediation model of functional capacity to relationship objective community 
function mediated by metacognition. Key: ***p<.001, ** p<.01, *p<.05 
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List of tables 
Table 1: Sample characteristics  
Sample characteristics Mean (SD) 
  
Age 26.08 (5.53 
Gender (M/F) 49/31 
Symptoms (positive) 12.01 (3.5) 
Symptoms (negative) 13.6 (4.92) 
Symptoms (general) 28.35 (6.7) 
Prescribed anti-psychotic medication (Y/N) 48/32 
Olanzapine equivalent dose (of those prescribed medication) (mg/day) 12.77 (7.79) 
 
Table 2: Variable mean scores and range 
Variables Raw score mean 
(SD) 
Range 
    
Neurocognition Logical Memory I (0-75) 27.7 (10.9) (10-55) 
 Logical Memory II (0-50) 16.28 (8.26) (0-35) 
 Letter-number Sequencing (0-21) 8.64 (2.46) (4-15) 
 Verbal Fluency (phonetic) 32.28 (10.27) (5-56) 
 Verbal Fluency (semantic) 18.49 (4.77) (9-29) 
 Matrix Reasoning (0-35) 25.82 (4.13) (13-34) 
 Vocabulary (0-80) 52.8 (11.67) (11-73) 
 Trailmaking Task (B-A) 37.99 (33.88)  
Metacognition (MAI) Monitoring(0-5) 2.93 (1.25) (0-5) 
 (MAI) Differentiation(0-5) 2.77 (1.17) (0-5) 
 (MAI) Integration(0-5) 2.83 (1.22) (0-5) 
 (MAI) Decentralism(0-5) 2.57 (1.43) (0-5) 
 (BCIS) Self-reflectivity(0-27) 14.3 (5.06) (0-5) 
 (BCIS) Self-certainty(0-18) 5.88 (2.88) (0-5) 
Functional  (UPSA) Finance  (0-20) 15.68 (3.06) (7.27-20) 
outcome (UPSA) Communication (0-20) 12.99 (3.69) (5-18.33) 
 (UPSA) Comprehension & planning (0-20) 12.48 (4.65) (0-20) 
 (UPSA) Transport (0-20) 15.12 (3.03) (8.89-20) 
 (UPSA) Household (0-20) 15.75 (4.42) (0-20) 
 (Time Use) Structured activity (total hours 
per week) 
24.97 (23.09) (2.3-96.74) 
Key: Scale total range indicated in brackets (x-x) 
Table 3: Bivariate correlations between variables 
 Education Neurocognition BCIS self-
reflectivity 
MAI UPSA Time 
Use 
Neurocognition .56*** 1     
Beck Cognitive Insight Scale: 
self-reflectivity 
.37** .19 1    
Synthetic metacognition (MAI) .56*** .61*** .43*** 1   
Functional capacity (UPSA) .57*** .70*** .31** .81*** 1  
Self-report social and 
occupational function (Time 
Use) 
.43** .48*** .33** .84*** .64*** 1 
***p<.001, ** p<.01, *p<.05 
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Table 4: Full list of mediation models with fit statistics  
Predictor 
 
Mediator 
 
Outcome Model fit 
(𝜒2 (df), p) 
CFI/TFI/RMSEA Indirect 
(a*b,[95%CI]) 
R2med R2out 
NC MC FX .03(1), .86 1.00, 1.04, .00 .40(.29)**[.07, .50] .313 .673 
NC MC FO .11(1), .74 1.00, 1.04, .00 18.55(.41) ***[.31, .64] .317 .594 
NC FX FO .00(0), .00a 1.00, 1.00, .00 18.74(.40) ***[.26, .55] .495 .413 
FX MC FO .17(1), 68 1.00, 1.00, 0.00 24.14(.41) ***[.31, .64] .314 .66 
NC MC, Neg FX .22(3), .00 .89, .63, .00 25.68(.60) **[.24, .95] .595 .71 
***=p<.001, **=p<.01, *= p<.05. Notes: NC=neurocognition, MC=metacognition, FX=functional 
capacity, FO=self-report structured activity, Neg=negative symptoms, a= just identified model, ( )= 
standardised value 
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